Congenital Hypothyroidism with Gland in situ is More Frequent than Previously Thought by Persani, Luca
Congenital hypothyroidism (CH) is the 
most common congenital endocrine dis-
ease and avoidable cause of severe mental 
retardation.  l-thyroxine supplementation 
started within 2–3 weeks of age can prevent 
severe neurological damage. Thus, neonatal 
screening programs have been instituted to 
allow early CH detection and initiation of 
therapy and still represent one of the major 
achievements of preventive medicine.
The use of different strategies has 
allowed the early detection of a larger num-
ber of CH cases, with a reported incidence 
of 1:3,000–4,000 newborns during the last 
decades of the twentieth century (Dussault, 
1999; Van Vliet and Czernichow, 2004; Rose 
et al., 2006; Rastogi and LaFranchi, 2010). 
Surprisingly, more recent observational 
studies reported an incidence reaching 
about 1:1,500 live newborns (Harris and 
Pass, 2007; Corbetta et al., 2009; Rastogi 
and LaFranchi, 2010). These studies were 
originally performed in New York State 
and in Lombardy (Italy) using two different 
screening strategies: T4 or TSH determina-
tion on dry blood spot (dbs), respectively.
These epidemiological changes are also 
accompanied by a modification of the usual 
CH features. The morphogenetic defects 
(athyreosis, ectopy, hemiagenesis, or hypo-
plasia) were indeed considered to account for 
about 75% of total cases, while the remain-
der had a thyroid gland in situ (GIS) either 
associated with transient or permanent 
functional defects (Dussault, 1999; Gruters 
et al., 2004; Van Vliet and Czernichow, 2004; 
Park and Chatterjee, 2005; Rose et al., 2006; 
Rastogi and LaFranchi, 2010; De Felice and 
Di Lauro, 2011). This classification is almost 
completely reversed by the recent reports, as 
the increased CH incidence is mainly due 
to an augmented detection of hypothyroid 
newborns with GIS, which accounted in 
Lombardy for about 2/3 of the examined 
CH population (Corbetta et al., 2009; 
Figure 1).
The possible explanations for these find-
ings are indeed multiple (Harris and Pass, 
2007; Corbetta et al., 2009; LaFranchi, 2010; 
Rastogi and LaFranchi, 2010; Table 1). In 
our case, the lower threshold for dbs–TSH 
screening (10 mU/L, equivalent to about 
20 mU/L in serum) led to an impres-
sive modification of CH epidemiology 
(Corbetta et al., 2009). In the last 2 years, 
the experience with lower TSH cutoffs 
was replicated in several countries includ-
ing Greece and Wales (Korada et al., 2010; 
Mengreli et al., 2010), thus confirming the 
existence of numerous false negative results 
by using a TSH threshold for newborn recall 
of 20 mU/L in dbs. These findings are the 
first giving support to the indication by the 
National Academy of Clinical Biochemistry 
(NACB) toward the use of lower TSH cutoffs 
for CH screening (Baloch et al., 2003). The 
implementation of NACB recommendation 
has been hampered mainly by the fear of an 
unjustified increase in the costs of screening 
programs and overload of pediatric refer-
ral centers. We estimated that the reduction 
of dbs–TSH cutoff in the years 1999–2005 
caused an increment of 22% in the number 
of tests per neonate/year (Corbetta et al., 
2009). This increment was the only relevant 
additional cost raised by the new screening 
strategy. Therefore, we and other consider 
that this effort may be justified since a pre-
viously unsuspected number of newborns 
with permanent “true” CH were detected 
at birth (Corbetta et al., 2009; Korada et al., 
2010; Mengreli et al., 2010). In addition, the 
possibility to have a more careful determi-
nation of the thyroid status in neonates at 
moderate risk of CH was in our experience 
well-received by most of the parents.
Nevertheless, an incidence similar to 
those observed in Italy and Greece was 
reported in USA by screening CH with dbs–
T4 determination (Harris and Pass, 2007). 
It is therefore likely that also other factors 
may contribute to the increased   incidence 
of functional thyroid defects among new-
borns. Certainly, ethnicity could have a 
role as in USA CH appears to be most and 
least frequent in the Asian (about 1:1,000) 
and Black (1:1,900) population, respec-
tively (Harris and Pass, 2007; Rastogi and 
LaFranchi, 2010). Therefore, changes in the 
ethnic distribution of newborns may con-
tribute to the observed rise of CH incidence 
in different countries.
Iodide deficiency is the environmen-
tal factor most widely associated with an 
increased prevalence of CH. Analysis of 
the prevalence of dbs–TSH values above 
5 mU/L (Zimmermann et al., 2005), unex-
pectedly revealed that one of the richest 
regions in Europe, such as Lombardy, is 
still characterized by a borderline-mild 
iodide deficiency during the last 10 years 
(5.4–6.3%; optimal iodide supply <3%; 
Corbetta et al., 2009). A lowering of 
iodide supply, possibly linked to different 
feeding habits and lifestyle of immigrant 
populations, has been suggested also to be 
involved in the New York state findings 
(Harris and Pass, 2007). Increased iodide 
load as may be observed in perinatal dis-
infection may also lead to higher dbs–TSH 
values and transient CH. However, iodide 
contamination is nowadays generally 
avoided during obstetric procedures and 
most of the cases with dbs–TSH values 
ranging 10–20 mU/L appear to be per-
manent (Corbetta et al., 2009; Mengreli 
et al., 2010).
Other mechanisms possibly contrib-
uting to the high incidence of functional 
defects include thyroid disrupting chemi-
cals and premature birth. Interestingly, 
higher neonatal TSH values have been 
reported in babies born in Lombardy from 
mothers exposed 25 years before to dioxin 
contamination during the ICMESA acci-
dent in Seveso during 1976 (Baccarelli et al., 
2008), suggesting that contaminants may 
have contributed to our findings.
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doi: 10.3389/fendo.2012.00018Our data revealed the frequent associa-
tion of CH with premature birth, which rep-
resents a condition with a three to fivefold 
increased risk of CH with GIS (Corbetta 
et al., 2009). Children born prematurely 
were reported to be predisposed to non-
autoimmune thyroid dysfunction as a likely 
consequence of the defective maturation 
of the hypothalamic–pituitary–thyroid 
axis (Radetti et al., 2007). Therefore, hypo-
thyroidism should be included among the 
frequent consequences of premature birth 
and might contribute to the developmental 
defects affecting children born prematurely 
(van Wasseraer et al., 1997; Stoelhorst et al., 
2005; LaHood and Bryant, 2007). Due to 
several factors, including the increased rate 
of multiple pregnancies, the number of pre-
mature children is diffusely growing in the 
recent years and survival of very pre-term 
infants is nowadays becoming frequent 
(Stoelhorst et al., 2005).
Since a defective neurological devel-
opment is the main consequence of 
untreated CH (LaFranchi, 2010; Rastogi 
and LaFranchi, 2010),  l-thyroxine was 
cautiously given to all confirmed hypo-
thyroid infants. The indication to give an 
early as possible treatment to these posi-
tive infants is emphasized by the observa-
tions of an impaired psycho-neurological 
outcome and subtle cognitive deficits in 
the treated CH population compared to 
unaffected siblings (Salerno et al., 1999; 
Rovet, 2005; Selva et al., 2005; Oerbeck 
et al., 2007) and by the impaired intellec-
tual development described in transient 
neonatal hypothyroidism and hyper-
thyrotropinemia (Calaciura et al., 1995; 
Azizi et al., 2001). On this basis, it is 
conceivable that a significant number of 
behavioral/neurological disorders (e.g., 
attention-deficit disorder) nowadays 
recognized later in life might be due to 
missed forms of neonatal CH. Since no 
evidence is presently available to support 
this view, other Authors consider at pre-
sent unjustified the additional efforts to 
diagnose and treat milder forms of CH as 
those associated with dbs–TSH ranging 
10–20 mU/L (Krude and Blankenstein, 
2011).
In conclusion, the use of low dbs–TSH 
cutoff for neonatal screening is associated 
with CH incidence about double than pre-
viously thought. This is mainly due to the 
detection of hypothyroid newborns with 
GIS, later evolving in permanent mild thy-
roid dysfunction. However, other factors 
(ethnic modifications in the screened pop-
ulation, variations in iodide supply, EDCs, 
multiple pregnancies, and premature birth) 
contribute to such an increased incidence of 
CH in most recent years. Indeed, premature 
birth represents a high risk condition for this 
type of CH. In contrast to what is currently 
known, inborn functional defects are notice-
ably prevalent over dysgenetic forms in the 
most recent CH population. Further studies 
are needed to define the appropriate treat-
ment and follow-up strategy for the large 
group of CH children that evolve toward a 
mild thyroid dysfunction later in life.
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